ECONOMICAL MULTIPLE-SITE INTRADERMAL IMMUNISATION WITH HUMAN DIPLOID-CELL-STRAIN VACCINE IS EFFECTIVE FOR POST-EXPOSURE RABIES PROPHYLAXIS
- 1 May 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 325 (8437) , 1059-1062
- https://doi.org/10.1016/s0140-6736(85)92367-0
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- MULTI-SITE INTRADERMAL AND MULTI-SITE SUBCUTANEOUS RABIES VACCINATION: IMPROVED ECONOMICAL REGIMENSThe Lancet, 1984
- AN ECONOMICAL REGIMEN OF HUMAN DIPLOID CELL STRAIN ANTI-RABIES VACCINE FOR POST-EXPOSURE PROPHYLAXISThe Lancet, 1983
- MULTISITE INTRADERMAL ANTIRABIES VACCINATIONThe Lancet, 1981
- POST EXPOSURE USE OF HUMAN DIPLOID CELL-CULTURE RABIES VACCINE1977
- Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serumJAMA, 1976
- Trial of human diploid cell rabies vaccine in human volunteers.BMJ, 1976
- Excretion of Street Rabies Virus in the Saliva of DogsJAMA, 1965